By
Trending Posts
Insilico Medicine Achieves Milestone with Positive Phase I…
CAMBRIDGE, Massachusetts, January 7, 2024 Insilico Medicine, a clinical-stage leader in generative AI-driven drug discovery and development, has…
Bristol Myers Squibb Taps AI-Driven Discovery with Terray…
Los Angeles – Dec 14, 2023 Terray Therapeutics, a leader in AI-driven small molecule discovery, has entered into…
PostEra and Amgen Forge AI Drug Discovery Partnership…
Boston – Nov 16, 2023 Advancing Small Molecule Therapeutics with AI PostEra has entered into a multi-target research…
NVIDIA Backs Terray Therapeutics to Advance Generative AI…
Los Angeles – Nov 9, 2023 Terray Therapeutics, a biotechnology company pioneering AI-driven small molecule discovery, has secured…
Merck (HQ Germany) Strengthens AI-Driven Drug Discovery with…
Darmstadt, Germany – Sept 20, 2023 Advancing AI-Powered Drug Development in Oncology, Neurology, and Immunology Merck, a global…
BenevolentAI Announces Strategic Collaboration with Merck, Darmstadt, Germany
London, UK – Sept 20, 2023 Partnership Utilizes AI-Driven Drug Discovery to Advance Oncology, Neurology, and Immunology Treatments…
XtalPi and Eli Lilly Partner in $250M AI-Driven…
Cambridge, MA – June 1 2023 XtalPi Inc., a pioneering AI-powered pharmaceutical technology company, has announced a strategic…
XtalPi and Janssen Partner to Accelerate AI-Driven Small…
Shenzhen, China – Oct 27 2022 XtalPi Inc., a leading AI-powered pharmaceutical technology company, announced a strategic research…
GSK Expands AI Capabilities with $70 Million Tempus…
London, UK – October 18, 2022 GSK has entered into a $70 million agreement with Tempus, a leader…
Trending Posts
Latest Stories
How Xsolis’ AI-Driven Dragonfly Clinched the 2025 MedTech’s ‘Clinical Efficiency Innovation Award’? Targets the $1 Trillion U.S. Healthcare Waste Crisis Clinical Efficiency Innovation Award
Key Highlights Xsolis Sets New Standard in AI-Powered Clinical EfficiencyTennessee-based AI tech firm Xsolis has…
25 AI-Driven Companies Leading, Top the 2025 Transformation: Are MedTech Giants Like Regeneron, PHC Holdings, and Henry Schein Redefining Global Healthcare?
Key Highlights AI-First Innovation Is No Longer Optional—It’s the Industry Standard The 2025 MedTech leaderboard…
How AccurKardia’s Award-Winning AccurECG™ Platform Redefine ECG Diagnostics with AI?
Key Highlights: A Landmark Recognition for a Game-Changing ECG Technology AccurKardia’s AccurECG™ has been named…
Can MIT and Recursion’s New AI Model Boltz-2 Slash Drug Discovery Time by 1000x and Outperform AlphaFold3?
Key Takeaways• Boltz-2 delivers AI-driven binding affinity predictions 1000x faster than traditional free energy methods—dramatically…
Gallery
